Accelerate Diagnostics, Inc.

Accelerate Diagnostics, Inc. has 1 AI-enabled medical device on the FDA list. The first decision was on September 15, 2020 and the most recent on September 15, 2020 (Accelerate Pheno System, Accelerate PhenoTest BC Kit). Its most common review panel is Microbiology (1 device).